NCT02740855View on ClinicalTrials.gov

Endtidal Ethanol in Sclerotherapy

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Ethanol Concentration
Interventions
DEVICE

Alcomed 3011®

Endtidal ethanol measurement

Trial Locations (1)

3011

Bern University Hospital and University of Bern, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02740855 - Endtidal Ethanol in Sclerotherapy | Biotech Hunter | Biotech Hunter